April 22, 2022 Perceptions of Parents, Nurses and Physicians Regarding Research Communication in the NICU: Results of an International Survey
April 14, 2022 Longtime Pharmaceutical Executive to Lead C-Path’s Sickle Cell Disease Consortium TUCSON, Ariz., April 14, 2022 – Critical Path Institute (C-Path) has named Sergey Rakhilin, Ph.D., as Executive Director of its
April 13, 2022-April 14, 2022 13th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 13–14, 2022 On April 13–14, 2022, the 13th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual for
April 12, 2022 RDCA-DAP Responsive Curation Levels – Dr. Ramona Walls This was presented as part of the RDCA-DAP monthly steering committee meeting, on April 12, 2022. It describes the 8 curation...
April 11, 2022 Quantitative System Pharmacology as a Legitimate Approach to Examine Extrapolation Strategies used to Support Pediatric Drug Development; Azer K, Barrett JS
April 11, 2022 Role of Disease Progression Models in Drug Development. Pharmaceutical Research; Jeffrey S Barrett, Tim Nicholas, Karim Azer, Brian W Corrigan
April 11, 2022 C-Path’s ePRO Consortium Announces Rebranding, Changes Name to eCOA Consortium TUCSON, Ariz., January 11, 2022 — Critical Path Institute (C-Path) is pleased to announce the Electronic Patient-Report
April 5, 2022 New logo! Rare Disease Cures Accelerator-Data and Analytics Platform has a new look! C-Path’s RDCA-DAP team is excited to unveil its new logo for the Rare Disease Cures Accelerator-Data and Analytics Platform